- Q2 2024 Eris Lifesciences Ltd Earnings Call TranscriptNov 08, 2023₹897.8 (+3.30%)Earnings
- Q1 2024 Eris Lifesciences Ltd Earnings Call TranscriptAug 07, 2023₹828.2 (+3.45%)Earnings
- Q4 2023 Eris Lifesciences Ltd Earnings Call TranscriptMay 17, 2023₹636.65 (+1.06%)Earnings
- Eris Lifesciences Ltd to Announce Acquisition of Nine Dermatology Brands From Dr Reddy's Laboratories Ltd Call TranscriptMar 16, 2023
- Q3 2023 Eris Lifesciences Ltd Earnings Call TranscriptJan 17, 2023₹651.8 (+0.50%)Earnings
- Q2 2023 Eris Lifesciences Ltd Earnings Call TranscriptOct 20, 2022₹707.85 (-2.92%)Earnings
- Q1 2023 Eris Lifesciences Ltd Earnings Call TranscriptAug 05, 2022₹694.75 (-0.81%)Earnings
- Q4 2022 Eris Lifesciences Ltd Earnings Call TranscriptMay 04, 2022₹663.35 (-1.86%)Earnings
- Q3 2022 Eris Lifesciences Ltd Earnings Call TranscriptJan 28, 2022₹696.2 (-2.04%)Earnings
- Eris Lifesciences Ltd To Discuss Joint Venture with Mj Biopharm Pvt Ltd Call TranscriptDec 04, 2021
- Q2 2022 Eris Lifesciences Ltd Earnings Call TranscriptOct 29, 2021₹821 (+4.73%)Earnings
- Q1 2022 Eris Lifesciences Ltd Earnings Call TranscriptJul 29, 2021₹771.15 (+3.91%)Earnings
- Q4 2021 Eris Lifesciences Ltd Earnings Call TranscriptMay 13, 2021₹653.85Earnings
- Q3 2021 Eris Lifesciences Ltd Earnings Call TranscriptJan 28, 2021₹623.1 (+2.03%)Earnings
- Q2 2021 Eris Lifesciences Ltd Earnings Call TranscriptNov 03, 2020₹518.1 (+1.46%)Earnings
- Q1 2021 Eris Lifesciences Ltd Earnings Call TranscriptAug 04, 2020₹510.95 (-5.48%)Earnings
- Q4 2020 Eris Lifesciences Ltd Earnings Call TranscriptJun 02, 2020₹519.2 (-1.59%)Earnings
- Q3 2020 Eris Lifesciences Ltd Earnings Call TranscriptFeb 14, 2020₹465.5 (-11.33%)Earnings
- Q2 2020 Eris Lifesciences Ltd Earnings Call TranscriptNov 07, 2019₹425.55 (+4.61%)Earnings
- Q1 2020 Eris Lifesciences Ltd Earnings Call TranscriptJul 29, 2019₹394.8 (-1.62%)Earnings
- Q4 2019 Eris Lifesciences Ltd Earnings Call TranscriptMay 21, 2019₹605.6 (-1.37%)Earnings
Q2 2020 Eris Lifesciences Ltd Earnings Call Transcript
Ladies and gentlemen, good day, and welcome to the Eris Lifesciences Q2 FY '20 Results Conference Call. (Operator Instructions)
Please note that this conference is being recorded. I now hand the conference over to Mr. Amit Bakshi, Managing Director. Thank you, and over to you.
Hello. I welcome everyone and thank you for joining for this call.
Let me begin by taking you through the presentation that we uploaded and then we can open for Q&A.
So far the quarter, we've grown by 9.4% versus -- what IPM, stood at 11.5% growth. In our Chronic and Sub Chronic therapy, which comprises around 86% of our business, we have grown 11.4% versus 10.6% for the IPM.
On -- we've also shared the secondary numbers for H1 '20, where the trend continues of Eris outperforming IPM in chronic, sub chronic segments. We also continue to have high ranks among our key specialties, fourth with cardiologists, third with diabetologists, gastroenterologists as well as neurologists.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)